As CAR-Ts Proliferate, CMS Seeks To Reserve Medicare Add-On Payments For ‘New’ Therapies

 
• By Cathy Kelly
New Phase Of Medicare Reimbursement Policy For CAR-T Therapies • Source: Alamy

More from Cell & Gene Therapies

More from Advanced Technologies